-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PJq1yAVSccwIQ4VZWz7/2mVWBapSn4EPu6ehkkLYfAk4+3c8rxncX42UGs9WGFO3 aD7t8OUq6EXjUdL2k3Vo3w== 0001193125-05-207357.txt : 20051025 0001193125-05-207357.hdr.sgml : 20051025 20051025073119 ACCESSION NUMBER: 0001193125-05-207357 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051020 ITEM INFORMATION: Other Events FILED AS OF DATE: 20051025 DATE AS OF CHANGE: 20051025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERISOURCEBERGEN CORP CENTRAL INDEX KEY: 0001140859 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 233079390 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16671 FILM NUMBER: 051153195 BUSINESS ADDRESS: STREET 1: 1300 MORRIS DRIVE, SUITE 100 CITY: CHESTERBROOK STATE: PA ZIP: 19087-5594 BUSINESS PHONE: 6107277000 MAIL ADDRESS: STREET 1: 1300 MORRIS DRIVE, SUITE 100 CITY: CHESTERBROOK STATE: PA ZIP: 19087-5594 8-K 1 d8k.htm AMERISOURCEBERGEN CORP--FORM 8-K AmerisourceBergen Corp--Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported): October 20, 2005

 

AmerisourceBergen Corporation

(Exact name of Registrant as specified in its charter)

 

Delaware   1-16671   23-3079390

(State or Other

Jurisdiction of Incorporation

or Organization)

   Commission File Number  

(I.R.S. Employer

Identification Number

 

 

1300 Morris Drive

Chesterbrook, PA

(Address of principal executive offices)

    19087
(Zip Code)
Registrant’s telephone number, including area code:    (610) 727-7000

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

 

AmerisourceBergen Corporation (the “Registrant”) has received notice of termination effective mid-December 2005 of its contract with United Drugs, a group purchasing organization for independent retail pharmacies. Notwithstanding the notice of termination, the Registrant expects to retain a substantial majority of its business with the members of United.

 

The Registrant expects that a large number of the members of United will terminate their affiliation with United and elect to continue to do business with the Registrant. Among other things, the majority of the members of United are participants in one or more of the Registrant’s retail programs, including Good Neighbor Pharmacy®, Performance Plus Network® and Diabetes Shoppe®, and a number of them also have separate contracts directly with the Registrant. However, there can be no assurance that the Registrant will retain a majority, or any, of the members of United as customers following the termination of the contract between the Registrant and United.

 

The Registrant believes that United has contracted with a competitor of the Registrant. Purchases by the members of United represented approximately 4% of the Registrant’s operating revenues for the nine months ended June 30, 2005.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     AMERISOURCEBERGEN CORPORATION

Date: October 25, 2005

    By:  

/s/ Michael D. DiCandilo

        

Name: Michael D. DiCandilo

        

Title:   Executive Vice President

        

  and Chief Financial Officer

 -----END PRIVACY-ENHANCED MESSAGE-----